IL99917A0 - Indole-and benzimidazole-substituted imidazole and benzimidazole derivatives and pharmaceutical compositions containing the same - Google Patents

Indole-and benzimidazole-substituted imidazole and benzimidazole derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL99917A0
IL99917A0 IL99917A IL9991791A IL99917A0 IL 99917 A0 IL99917 A0 IL 99917A0 IL 99917 A IL99917 A IL 99917A IL 9991791 A IL9991791 A IL 9991791A IL 99917 A0 IL99917 A0 IL 99917A0
Authority
IL
Israel
Prior art keywords
benzimidazole
indole
pharmaceutical compositions
same
compositions containing
Prior art date
Application number
IL99917A
Other languages
English (en)
Inventor
Michael Anthony Poss
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of IL99917A0 publication Critical patent/IL99917A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL99917A 1990-10-31 1991-10-31 Indole-and benzimidazole-substituted imidazole and benzimidazole derivatives and pharmaceutical compositions containing the same IL99917A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60663190A 1990-10-31 1990-10-31

Publications (1)

Publication Number Publication Date
IL99917A0 true IL99917A0 (en) 1992-08-18

Family

ID=24428787

Family Applications (1)

Application Number Title Priority Date Filing Date
IL99917A IL99917A0 (en) 1990-10-31 1991-10-31 Indole-and benzimidazole-substituted imidazole and benzimidazole derivatives and pharmaceutical compositions containing the same

Country Status (23)

Country Link
EP (1) EP0488532A1 (fi)
JP (1) JPH0592969A (fi)
KR (1) KR920008032A (fi)
CN (1) CN1061224A (fi)
AU (1) AU650294B2 (fi)
CA (1) CA2054594A1 (fi)
CS (1) CS330591A3 (fi)
EG (1) EG19826A (fi)
FI (1) FI915148A (fi)
HU (1) HU214575B (fi)
IE (1) IE913785A1 (fi)
IL (1) IL99917A0 (fi)
MX (1) MX9101873A (fi)
MY (1) MY108611A (fi)
NO (1) NO180749C (fi)
NZ (1) NZ240383A (fi)
PH (1) PH31175A (fi)
PL (1) PL168902B1 (fi)
PT (1) PT99404A (fi)
RO (1) RO109735B1 (fi)
RU (1) RU2111208C1 (fi)
YU (1) YU173791A (fi)
ZA (1) ZA918688B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT95899A (pt) * 1989-11-17 1991-09-13 Glaxo Group Ltd Processo para a preparacao de derivados indole
GB9113628D0 (en) * 1991-06-25 1991-08-14 Ici Plc Heterocyclic derivatives
GB9113626D0 (en) * 1991-06-25 1991-08-14 Ici Plc Heterocyclic compounds
CA2109932A1 (en) * 1992-03-25 1993-09-30 Yoshihisa Inoue Isoindazole compound
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
CA2109931A1 (en) * 1992-03-27 1993-10-14 Hiroshi Matsui Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor
US5538973A (en) * 1992-03-27 1996-07-23 Kyoto Pharmaceutical Industries, Ltd. Imidazole derivative, pharmaceutical use thereof, and intermediate therefor
GB9218449D0 (en) 1992-08-29 1992-10-14 Boots Co Plc Therapeutic agents
AU675484B2 (en) * 1993-03-24 1997-02-06 Neurosearch A/S Benzimidazole compounds, their use and preparation
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
KR20070028553A (ko) 2004-06-18 2007-03-12 바이올리폭스 에이비 염증 치료에 유용한 인돌
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US8013006B2 (en) 2004-07-14 2011-09-06 Ptc Therapeutics, Inc. Methods for treating hepatitis C
EP1781289A1 (en) 2004-07-22 2007-05-09 PTC Therapeutics, Inc. Thienopyridines for treating hepatitis c
BRPI0519774A2 (pt) 2005-01-19 2009-02-10 Biolipox Ab composto ou um sal farmaceuticamente aceitÁvel do mesmo, formulaÇço farmacÊutica, uso de um composto ou um sal farmaceuticamente aceitÁvel do mesmo, mÉtodo de tratamento de uma doenÇa em que inibiÇço da atividade de um membro da famÍlia mapeg É desejada e/ou necessÁria, produto combinado, e, processo para a preparaÇço de um composto
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
EP2527360B1 (en) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN103965167A (zh) * 2013-01-29 2014-08-06 通化济达医药有限公司 咪唑羧酸衍生物
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
CN106397414A (zh) * 2015-08-14 2017-02-15 陈志龙 杂螺环酮吲哚衍生物的一种制备方法
CN113999204B (zh) * 2021-11-08 2023-09-05 常州大学 一种非手性咪唑型离子化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826862A (en) * 1988-02-12 1989-05-02 Janssen Pharmaceutica, N.V. Anthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamates
GB8820231D0 (en) * 1988-08-25 1988-09-28 Fujisawa Pharmaceutical Co New benzazole compounds processes for preparation thereof & pharmaceutical composition comprising same
PT95899A (pt) * 1989-11-17 1991-09-13 Glaxo Group Ltd Processo para a preparacao de derivados indole
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung

Also Published As

Publication number Publication date
NO180749C (no) 1997-06-11
JPH0592969A (ja) 1993-04-16
ZA918688B (en) 1992-08-26
AU650294B2 (en) 1994-06-16
EG19826A (en) 1996-03-31
MX9101873A (es) 1992-06-05
HUT59677A (en) 1992-06-29
CA2054594A1 (en) 1992-05-01
YU173791A (sh) 1994-01-20
CN1061224A (zh) 1992-05-20
PL168902B1 (pl) 1996-05-31
NZ240383A (en) 1994-12-22
IE913785A1 (en) 1992-05-22
AU8691091A (en) 1992-05-07
HU214575B (hu) 1998-04-28
MY108611A (en) 1996-10-31
PT99404A (pt) 1992-09-30
NO914263D0 (no) 1991-10-30
PL292249A1 (en) 1992-07-13
NO180749B (no) 1997-03-03
NO914263L (no) 1992-05-04
FI915148A0 (fi) 1991-10-31
EP0488532A1 (en) 1992-06-03
HU913418D0 (en) 1992-01-28
FI915148A (fi) 1992-05-01
RU2111208C1 (ru) 1998-05-20
KR920008032A (ko) 1992-05-27
PH31175A (en) 1998-03-20
RO109735B1 (ro) 1995-05-30
CS330591A3 (en) 1992-06-17

Similar Documents

Publication Publication Date Title
IL99917A0 (en) Indole-and benzimidazole-substituted imidazole and benzimidazole derivatives and pharmaceutical compositions containing the same
IL113196A0 (en) Imidazole derivatives and pharmaceutical compositions containing the same
IL106431A0 (en) Aminediol derivatives and pharmaceutical compositions containing the same
IL105806A0 (en) Aminoquinoline derivatives and pharmaceutical compositions containing the same
HK1005448A1 (en) Imidazole compounds and blocidal compositions comprising the same
IL114492A0 (en) Benzimidazole derivatives their preparation and pharmaceutical compositions containing them
NZ226483A (en) Substituted imidazole derivatives and pharmaceutical compositions
IL135366A0 (en) Substituted benzoxazoles and pharmaceutical compositions containing the same
IL106553A0 (en) Substituted imidazoles and pharmaceutical compositions containing them
IL98873A0 (en) Benzodiazepine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL143802A0 (en) Imidazole derivatives and pharmaceutical compositions containing the same
IL98239A0 (en) Benzopyran derivatives and heterocyclic analogs thereof and pharmaceutical compositions containing the same
SG46197A1 (en) Optically active triazole derivatives and compositions
IL105356A0 (en) Benzimidazoles,their preparation and pharmaceutical compositions containing them
IL106408A0 (en) Benzimidazoles,their preparation and pharmaceutical compositions containing them
HUP9904301A3 (en) Benzimidazole derivatives and pharmaceutical compositions containing them
IL104471A0 (en) Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL104347A0 (en) Substituted benzimidazole derivatives,their preparation and pharmaceutical compositions containing them
IL99454A0 (en) Monosaccharide derivatives and pharmaceutical compositions containing the same
IL102116A (en) Hetaryloxy-beta-carboline derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL100274A0 (en) Vinyl azole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NZ239483A (en) Phosphonopyrrolidine or -piperidine derivatives and pharmaceutical compositions
IL118411A0 (en) 2-Substituted benzimidazole derivatives and pharmaceutical compositions containing them
IL115982A0 (en) Cyclolignan derivatives and pharmaceutical compositions containing the same
GB9001886D0 (en) Pharmaceutical formulation